N/A Completed N=40 Randomized Health Services Research

The Effects of a Jump Rope Exercise Program on Vascular Health, Inflammatory Markers in Prehypertensive Adolescent Girls

Prehypertension · Blood Pressure · Obesity · Adiposity

Source: ClinicalTrials.gov NCT03534427 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2019

Primary outcomePrimary: Arterial Stiffness — 8.1; 7.4 m/s

Summary

The purpose of this study was to examine the impact of a 12-week jump rope exercise program on blood pressure, arterial stiffness, vasodilating and vasoconstricting factors, inflammatory markers, and body composition in prehypertensive adolescent girls. Forty prehypertensive adolescent girls participated in this study. The girls were randomly divided into the jump rope exercise intervention group (EX, n=20) and control group (CON, n=20). The EX group performed a jump rope training program at 40-70% of their heart rate reserve (HRR) 5 days/week for 12 weeks (sessions 50 minutes in duration). The CON group did not participate in any structured or unstructured exercise protocol. Blood pressure, arterial stiffness, plasma nitrate/nitrite levels, endothelin-1, C-reactive protein, and body composition were measured before and after the 12-weeks study.

Outcome Measures

Outcome	Result	p-value
PRIMARY Arterial Stiffness	8.1; 7.4	—
PRIMARY Endothelin-1	0.4; 0.38	—
PRIMARY Body Mass	70; 66	—
PRIMARY Height	162; 161	—
PRIMARY Waist Circumference	84.4; 80.1	—
PRIMARY Body Fat	33.5; 30.2	—
PRIMARY Lean Body Mass	42.8; 45.9	—
PRIMARY Nitrate/Nitrite Levels	53.5; 57.2	—
PRIMARY C-reactive Protein	0.7; 0.2	—
PRIMARY Systolic Blood Pressure	127; 120	—
PRIMARY Diastolic Blood Pressure	84; 80	—

Eligibility Criteria

Inclusion Criteria

prehypertensive
sedentary (no regular exercise training or physical activity within the last year)
no weight loss diet during the last six months

Exclusion Criteria

pregnancy
chronic disease
daily medication use (including antioxidants and weight loss supplements)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03534427). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.